OneSource Medical Group in Florida has entered into an agreement to distribute NeuroMetrix's transcutaneous electrical nerve stimulator, designed to help manage chronic pain in diabetes patients with painful diabetic neuropathy.
The FDA-cleared pain management device, SENSUS, can also be used to treat chronic intractable pain in the lower leg and foot.
The low profile, light weight device is worn on the upper calf or under the clothing and is activated by the press of a single button.
NeuroMetrix president and chief executive officer Shai Gozani said, "OneSource Medical Group’s diabetes focus makes them a natural partner for SENSUS launch."
One Source Medical Group chief operating officer Eric Sternberg said the company is impressed with the SENSUS design features and convenience for patient use.
"SENSUS fits nicely into our diabetes product suite which today includes blood glucose meters, pumps, syringes and other products," Sternberg added.
"We anticipate strong interest from our physician clientele."